Newstral
Article
triblive.com on 2015-07-27 14:09
Israel’s Teva drops bid for Mylan, buys Allergan for $40.5B
Related news
- Israel’s Teva buys Allergan generic drug company for $40.5Bneworleanscitybusiness.com
- Teva buys Allergan for $40.5b.Ynetnews
- Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
- Israel's Teva buys Allergan generic drug company for $40.5BStar Telegram
- Israel’s Teva buys Allergan drug company for $40.5 billiontimesofisrael.com
- Israel’s Teva buys Allergan generic drug company for $40.5 billionpressherald.com
- Teva buying Allergan, drops Mylan bidPhilly.com
- Teva buys Allergan generic drug firm for $40.5BUSA today
- In Israel's largest acquisition, Teva buys Allergan Generics for $40.5bThe Jerusalem Post (JPost.com)
- Teva abandons Mylan takeover bid in favor of Allergan dealobserver-reporter.com
- Teva buys Allergan for $40.5 billionjewishjournal.com
- Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail
- Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com